GleamWall
中文EN

CVM CEL SCI CORP

Biological Products, (No Diagnostic Substances) · NYSE · SEC CIK 725363 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY12.9%
TTM EPS YoY81.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-252.5%
ROA-108.9%
ROIC (approx.)-364.5%
Asset turnover—

Leverage & solvency

Liabilities / assets48.7%
Debt / equity0.00x
Current ratio1.48x
Interest coverage-50.08x

Cash quality & payout

Operating cash flow / net income0.74x
Accruals ratio-28.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue——
R&D expense$15.89M$18.16M
SG&A expense$8.92M$8.19M
Operating income-$24.81M-$26.35M
Interest expense$649,000$746,000
Net income-$25.41M-$26.92M
EBITDA-$22.75M-$24.22M
EPS (diluted)-6.27-15.31
Weighted avg. shares (diluted)4.06M1.80M
Banking
Net interest income-$648,944-$745,673
Balance sheet
Cash & equivalents$10.95M$4.74M
Inventory—$1.02M
Current assets$11.60M$6.06M
PP&E, net$6.08M$8.13M
Intangibles$119,856$165,492
Total assets$28.16M$26.99M
Current liabilities$5.13M$4.62M
Short-term debt$2.27M—
Long-term debt$5.68M—
Total debt$7.96M—
Total liabilities$12.20M$14.12M
Shareholders' equity$15.96M$12.87M
Net debt-$3.00M—
Shares outstanding8.02M2.13M
Cash flow statement
Operating cash flow-$17.12M-$18.81M
Capital expenditure$38,109$94,875
Free cash flow-$17.16M-$18.91M
Investing cash flow-$38,109-$108,086
Financing cash flow$23.37M$19.51M
Depreciation & amortization$2.06M$2.13M
Stock-based compensation$1.91M$4.27M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.